Nasdaq: RADX

Radiopharm Theranostics Ltd (RADX)

Radiopharm Theranostics Ltd is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker RADX. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
RADX
Exchange
Nasdaq
SEC CIK
1949257
Official filings
SEC EDGAR

Research RADX

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Radiopharm Theranostics Ltd's stock ticker?

Radiopharm Theranostics Ltd trades under the ticker symbol RADX on Nasdaq. Its SEC Central Index Key (CIK) is 1949257.

Where can I read Radiopharm Theranostics Ltd's SEC filings?

The RADX SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Radiopharm Theranostics Ltd has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze RADX's financial statements?

The RADX Financials page shows Radiopharm Theranostics Ltd's income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does RADX compare with its peers and the market?

The RADX Peer Comparison page lines Radiopharm Theranostics Ltd up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.